Literature DB >> 33016871

Role of pre-biopsy multiparametric MRI in prostate cancer diagnosis: Evidence from the literature.

David Ka-Wai Leung1, Peter Ka-Fung Chiu1, Chi-Fai Ng1, Jeremy Yuen-Chun Teoh1.   

Abstract

As the conventional workup for diagnosing prostate cancer, transrectal systematic biopsy carries the risk of sepsis and overdiagnosis of insignificant prostate cancer. In recent years, multiparametric MRI (mpMRI) has revolutionized the diagnostic approach to prostate cancer. With widespread use of the prostate imaging and data system (PIRADS), MRI reporting has been more standardized. Several landmark papers have indicated that mpMRI in combination with targeted or combined biopsy can confidently diagnose more clinically significant prostate cancer while reducing diagnoses of insignificant disease. In this review, we aim to discuss the advantages of pre-biopsy MRI based on the current literature and to address its reliability in ruling out prostate cancer, reproducibility, and cost-effectiveness.

Entities:  

Year:  2020        PMID： 33016871      PMCID： PMC8057361          DOI： 10.5152/tud.2020.20360

Source DB:  PubMed          Journal:  Turk J Urol        ISSN： 2149-3235


  26 in total

1.  A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.

Authors:  Peter K-F Chiu; Chi-Fai Ng; Axel Semjonow; Yao Zhu; Sébastien Vincendeau; Alain Houlgatte; Massimo Lazzeri; Giorgio Guazzoni; Carsten Stephan; Alexander Haese; Ilse Bruijne; Jeremy Yuen-Chun Teoh; Chi Ho Leung; Paola Casale; Chih Hung Chiang; Lincoln Guan-Lim Tan; Edmund Chiong; Chao Yuan Huang; Hsi Chin Wu; Daan Nieboer; Ding-Wei Ye; Chris H Bangma; Monique J Roobol
Journal:  Eur Urol       Date:  2018-11-02       Impact factor: 20.096

2.  Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect.

Authors:  Nathan Perlis; Thamir Al-Kasab; Ardalan Ahmad; Estee Goldberg; Kamel Fadak; Rashid Sayyid; Antonio Finelli; Girish Kulkarni; Rob Hamilton; Alexandre Zlotta; Sangeet Ghai; Neil Fleshner
Journal:  J Urol       Date:  2017-11-23       Impact factor: 7.450

3.  Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.

Authors:  Antonio C Westphalen; Charles E McCulloch; Jordan M Anaokar; Sandeep Arora; Nimrod S Barashi; Jelle O Barentsz; Tharakeswara K Bathala; Leonardo K Bittencourt; Michael T Booker; Vaughn G Braxton; Peter R Carroll; David D Casalino; Silvia D Chang; Fergus V Coakley; Ravjot Dhatt; Steven C Eberhardt; Bryan R Foster; Adam T Froemming; Jurgen J Fütterer; Dhakshina M Ganeshan; Mark R Gertner; Lori Mankowski Gettle; Sangeet Ghai; Rajan T Gupta; Michael E Hahn; Roozbeh Houshyar; Candice Kim; Chan Kyo Kim; Chandana Lall; Daniel J A Margolis; Stephen E McRae; Aytekin Oto; Rosaleen B Parsons; Nayana U Patel; Peter A Pinto; Thomas J Polascik; Benjamin Spilseth; Juliana B Starcevich; Varaha S Tammisetti; Samir S Taneja; Baris Turkbey; Sadhna Verma; John F Ward; Christopher A Warlick; Andrew R Weinberger; Jinxing Yu; Ronald J Zagoria; Andrew B Rosenkrantz
Journal:  Radiology       Date:  2020-04-21       Impact factor: 11.105

4.  The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction.

Authors:  Florian A Distler; Jan P Radtke; David Bonekamp; Claudia Kesch; Heinz-Peter Schlemmer; Kathrin Wieczorek; Marietta Kirchner; Sascha Pahernik; Markus Hohenfellner; Boris A Hadaschik
Journal:  J Urol       Date:  2017-03-31       Impact factor: 7.450

5.  Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.

Authors:  Arnout R Alberts; Monique J Roobol; Jan F M Verbeek; Ivo G Schoots; Peter K Chiu; Daniël F Osses; Jasper D Tijsterman; Harrie P Beerlage; Christophe K Mannaerts; Lars Schimmöller; Peter Albers; Christian Arsov
Journal:  Eur Urol       Date:  2018-08-03       Impact factor: 20.096

6.  Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.

Authors:  Nienke L Hansen; Tristan Barrett; Claudia Kesch; Lana Pepdjonovic; David Bonekamp; Richard O'Sullivan; Florian Distler; Anne Warren; Christina Samel; Boris Hadaschik; Jeremy Grummet; Christof Kastner
Journal:  BJU Int       Date:  2017-11-15       Impact factor: 5.588

Review 7.  Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Authors:  Baris Turkbey; Andrew B Rosenkrantz; Masoom A Haider; Anwar R Padhani; Geert Villeirs; Katarzyna J Macura; Clare M Tempany; Peter L Choyke; Francois Cornud; Daniel J Margolis; Harriet C Thoeny; Sadhna Verma; Jelle Barentsz; Jeffrey C Weinreb
Journal:  Eur Urol       Date:  2019-03-18       Impact factor: 20.096

8.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

9.  Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?

Authors:  Jeremy Yc Teoh; Steffi Kk Yuen; James Hl Tsu; Charles Kw Wong; Brian Sh Ho; Ada Tl Ng; Wai-Kit Ma; Kwan-Lun Ho; Ming-Kwong Yiu
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

10.  What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.

Authors:  Joseph M Norris; Lina M Carmona Echeverria; Simon R J Bott; Louise C Brown; Nick Burns-Cox; Tim Dudderidge; Ahmed El-Shater Bosaily; Eleni Frangou; Alex Freeman; Maneesh Ghei; Alastair Henderson; Richard G Hindley; Richard S Kaplan; Alex Kirkham; Robert Oldroyd; Chris Parker; Raj Persad; Shonit Punwani; Derek J Rosario; Iqbal S Shergill; Vasilis Stavrinides; Mathias Winkler; Hayley C Whitaker; Hashim U Ahmed; Mark Emberton
Journal:  Eur Urol       Date:  2020-05-01       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.